CION Ameerpet
Kidney cancer · Common questions
Kidney cancer vs kidney disease — and where kidney failure fits in
No, they are not the same thing. Kidney cancer is a growth — cells in the kidney multiply and form a tumour. Kidney disease is a loss of filtering function, and kidney failure is that loss at its most advanced. One is a problem of structure that a scan shows; the other is a problem of function that blood and urine tests measure. This page separates the three plainly, then covers the places where they genuinely touch — because they do.
- Structure versus function — a tumour is seen on imaging; kidney disease is measured as creatinine, eGFR and protein in the urine. Different question, different test.
- You can have one without the other — a normal kidney function report does not rule out a tumour, and a low eGFR is far more often chronic kidney disease than cancer.
- Where they do overlap — shared risk factors, acquired cysts after years on dialysis, and the filtering capacity you are left with once a tumour has been treated.
- 45-minute consultation, free — a senior medical oncologist reads your scan report alongside your creatinine, your eGFR and your urine results, and tells you which problem you are actually dealing with.
17+
Cancer Specialists
on Panel
on Panel
35+
Centres across
Telangana & AP
Telangana & AP
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
The direct answer
No — and the difference is structure versus function
Kidney cancer is a growth. Cells in the kidney multiply and form a tumour, most often in one kidney. In adults that tumour is usually a renal cell carcinoma, which begins in the lining of the tiny tubes that do the filtering. It is a change in the structure of the organ, which is why it is found by looking — an ultrasound first, then a contrast CT or an MRI to characterise anything solid. Most kidney cancers cause no symptoms early on, and a great many are picked up by accident on a scan ordered for something else entirely.
Chronic kidney disease is a loss of filtering capacity. The kidneys clean the blood, balance salts and water, help control blood pressure and support the making of red blood cells. When that work declines over months or years — usually across both kidneys at once — that is chronic kidney disease. It is a change in function, so it is measured rather than seen: creatinine in the blood, converted into an eGFR figure, together with protein or albumin in the urine. Those two measurements are what the stages from 1 to 5 are built on. Diabetes and long-standing high blood pressure are the commonest causes, with inflammation of the filtering units, inherited conditions such as polycystic kidney disease, long-term blockage of urine flow and certain medicines behind many of the rest.
Kidney failure is the far end of that same scale, not a third disease. End-stage kidney disease means filtering has fallen so low that the body cannot manage without help, and dialysis or a transplant is needed. It is where untreated or advancing chronic kidney disease can end up. A separate situation, often confused with it, is acute kidney injury — a sudden drop in function over hours or days from dehydration, severe infection, an obstruction or a drug reaction — which frequently recovers once the cause is dealt with.
Different tests, different specialists, different treatment. A nephrologist — a kidney physician — leads chronic kidney disease and kidney failure, and the goal is to slow the decline: control blood pressure and diabetes, adjust medicines, manage diet, and prepare for dialysis or transplant only if it comes to that. Kidney cancer is led by a medical oncologist working with urology and uro-oncology, and the goal is to remove or destroy the tumour where it is confined, or to control it with drug treatment where it is not. Neither treatment does the other's job. The full picture of the cancer side — types, symptoms, diagnosis, staging and treatment — sits in our kidney cancer guide.
The words themselves cause much of the trouble. “Renal” simply means kidney, so a report can say renal mass or renal lesion when it means a growth, and renal impairment or renal insufficiency when it means reduced filtering. Those are opposite findings that look similar on paper. In ordinary clinical conversation “kidney disease” means chronic kidney disease and does not imply cancer at all. And a mass on a scan is not a verdict either: among the small solid kidney masses that get investigated properly, up to a third turn out to be benign. If your report uses one of these phrases and nobody has explained it, book a free consultation and have it read line by line.
You will not find risk percentages for either condition on this page. Published figures describe populations, and a population figure tells you nothing reliable about the report in your hand. What does tell you something is the pairing of your imaging with your kidney function results, read together by someone who treats both problems.
Did you know?
Kidney function is measured across both kidneys together. One kidney can be doing considerably less than it should while the eGFR on your report still reads normal, because the other one takes up the slack. That is why a normal kidney function result is reassurance about filtering, not about structure — and why a tumour is looked for with a scan, never with a blood test.
Side by side
Kidney cancer, chronic kidney disease and kidney failure
A general comparison to help you read your own report. It is not a way to work out which one you have — only a doctor who has seen your imaging and your blood and urine results can tell you that.
| Kidney cancer | Chronic kidney disease | Kidney failure | |
|---|---|---|---|
| What it is | A tumour growing in kidney tissue — a change in structure. | Filtering capacity declining over months or years — a change in function. | The most advanced stage of chronic kidney disease, where filtering can no longer sustain the body. |
| Which kidney | Usually one. Tumours in both kidneys happen but are much less common. | Almost always both, because the causes act on the whole filtering system. | Both, by definition. |
| How it is usually found | On imaging — frequently by accident, on a scan ordered for something else. | On blood and urine tests, often during monitoring for diabetes or blood pressure. | On the same tests, as the numbers reach the most advanced stage. |
| What the tests show | A mass on ultrasound; its size, its blood supply and whether it takes up contrast on CT or MRI. | A falling eGFR, a rising creatinine, and protein or albumin appearing in the urine. | eGFR at its lowest range, usually with symptoms from waste and fluid building up. |
| Who leads the care | A medical oncologist, with urology and uro-oncology. | A nephrologist, with your family doctor or diabetes team. | A nephrologist and the dialysis or transplant team. |
| What treatment aims to do | Remove or destroy the tumour where it is confined; control it with drug treatment where it is advanced. | Slow the decline — blood pressure and diabetes control, medicine review, diet, protecting what remains. | Replace the filtering work with dialysis, or restore it with a transplant. |
| Effect on kidney function | Often little or none at first; treatment that removes kidney tissue is what reduces it. | Reduced function is the condition itself. | Function is too low to manage without dialysis or a transplant. |
One line worth holding on to: a scan answers “is there something there?” and a blood test answers “how well is it working?”. Neither question answers the other, which is why both belong in the same appointment.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Two different problems need two different plans
Bring the scan report and the blood and urine results to the same appointment. Read together, they usually settle in 45 minutes what weeks of searching could not.
Where the two genuinely meet
Separate conditions — but six real points of contact
Being clear that they are different diseases is not the same as saying they never interact. These are the overlaps that change what a specialist does.
Shared causes
Some risk factors push both ways
High blood pressure, excess body weight and smoking appear on the risk list for kidney cancer and for chronic kidney disease alike, and diabetes is a leading cause of kidney disease. Someone carrying those risks may be building both problems quietly and at the same time — which is an argument for having function checked and structure looked at, not for assuming one explains the other.
Years on dialysis
Acquired cysts change the picture
Long-term dialysis and advanced chronic kidney disease are associated with acquired cystic kidney disease, in which multiple cysts form in kidneys that have shrunk and lost function. Kidney cancer is found more often in that setting. It does not mean the disease turns into cancer — it means those kidneys warrant attention. Dialysis, chronic kidney disease and acquired kidney cysts covers what that monitoring involves.
After treatment
Treating the cancer can lower function
This is the commonest crossing point of all. Removing a tumour means removing kidney tissue with it, so creatinine rises and eGFR falls, then settles as the remaining kidney takes on more of the work over the following weeks and months. For some people the new baseline sits inside a chronic kidney disease category. Kidney function after nephrectomy explains what those numbers do and what is tracked afterwards.
Reduced function first
Existing kidney disease reshapes the work-up
When filtering is already reduced, the contrast dye used for CT has to be thought about carefully, so an ultrasound, a non-contrast scan or an MRI may be chosen instead, and the decision is made jointly with your kidney doctor. It also raises the priority of sparing healthy tissue, and it can make close monitoring rather than immediate treatment the better option for a small tumour under NCCN guidance.
Drug treatment
Kidney function is watched throughout
Where advanced kidney cancer needs drug treatment, kidney health stays on the checklist. VEGF-targeted therapy can raise blood pressure and push protein into the urine, so both are monitored on schedule; immunotherapy can trigger immune-related inflammation in the kidney, which is why bloods are repeated regularly. Classes and mechanisms are the level this page works at — specific drug choices belong in kidney cancer treatment in Hyderabad.
The team
Both doctors in the same conversation
When someone has kidney disease and kidney cancer together, the two plans have to be built as one. At CION every patient goes to a tumour board rather than one doctor's opinion, and where a nephrologist is already involved their input shapes imaging choices, how much kidney is spared and how drug treatment is monitored. Diagnosis, drug treatment and follow-up are led in-house by medical oncology.
In practice
How a specialist tells them apart — step by step
Nothing here is exotic. It is the ordinary sequence, and it is worth knowing because it shows exactly which test answers which question.
The history, the blood pressure and the medicine list
How long the problem has been building, whether there is diabetes or long-standing high blood pressure, what medicines are being taken, whether kidney disease runs in the family, and whether there has been blood in the urine, a one-sided ache, weight loss you cannot explain or a fever that keeps returning. This alone shifts the odds considerably before a single test is ordered.
Blood and urine — the function question
Creatinine gives the eGFR, which is the working measure of filtering. A urine test looks for protein or albumin and for blood, including blood you cannot see. Together these say how well the kidneys are working and, repeated over time, whether that is stable or slipping. What they cannot do is show a tumour. These tests are arranged and reported in-house at CION.
Ultrasound — the first look at structure
A quick, painless scan with no radiation and no dye. It shows the size and shape of both kidneys, whether urine is backing up, whether there are cysts or stones, whether the kidneys look small and scarred as they often do in long-standing kidney disease, and whether there is a solid mass. It is usually the point at which the two paths separate. Done in-house at CION.
Contrast CT or MRI — characterising anything solid
If something solid or complex is there, a contrast CT of the abdomen, or an MRI where contrast is unsuitable, describes its size, whether it takes up contrast and whether anything sits outside the kidney. A biopsy is added when imaging leaves the question open. If filtering is already reduced, the choice of scan and dye is made together with your kidney doctor. All of this imaging and reporting is in-house at CION.
The referral that follows — and it may be both
Reduced function with no mass goes to a nephrologist. A suspicious mass goes to medical oncology with urology and uro-oncology. Both findings mean both teams, working from one plan rather than two. Nobody should be left holding a report and guessing which door to knock on, and that is the point at which most of the anxiety around this question actually resolves.
If it is cancer, what the plan protects
For a confined tumour the aim is to clear it while keeping as much working kidney as possible; where surgery or ablation is the right answer, CION coordinates it with specialist urology, uro-oncology and interventional radiology teams at partner centres. Where advanced disease needs drug treatment, immunotherapy, combination immunotherapy and targeted or mTOR-pathway therapy are medical-oncology led and given in-house, with kidney function tracked throughout. Kidney cancer treatment in Hyderabad sets out the full range and how the choice is made.
One appointment, both questions
Stop guessing which one your report describes
Bring the scan, the blood results and the urine results. You will leave knowing which problem you have, which specialist leads it, and what happens next.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Kidney cancer vs kidney disease - your questions answered
Is kidney cancer the same as kidney disease?
No. Kidney cancer is a growth — cells in the kidney multiply and form a tumour, usually in one kidney. Chronic kidney disease is a loss of filtering function, usually across both kidneys, that builds up over months or years. One is a problem of structure, the other a problem of function, and they are found by different tests: imaging shows a tumour, while blood and urine tests show how well the kidneys are filtering. They are led by different specialists, and you can have either one without the other. Much of the confusion is linguistic — in everyday medical conversation kidney disease means chronic kidney disease, not cancer.
Does kidney cancer cause kidney failure?
Usually not by itself. Most kidney cancers start in one kidney, and a healthy kidney on the other side can carry much of the filtering load for both, so overall function often stays in a workable range. Kidney failure becomes a real concern in a narrower set of situations: when both kidneys carry tumours, when a tumour blocks the drainage of urine, when kidney function was already reduced before the diagnosis, or when treatment has to remove a large amount of working kidney tissue. That is why kidney function is measured before treatment is planned rather than only afterwards, and why sparing healthy kidney tissue is weighed carefully against clearing the tumour.
Can chronic kidney disease or dialysis lead to kidney cancer?
There is a recognised association. People on long-term dialysis, and people with advanced chronic kidney disease, more often develop acquired cystic kidney disease — multiple cysts forming in kidneys that have shrunk and lost function — and kidney cancer is found more often in that setting than in the general population. That does not mean chronic kidney disease turns into cancer, and it does not mean anyone on dialysis should expect a diagnosis. It means the kidneys of someone on long-term dialysis are worth keeping an eye on, and that a new symptom or a new imaging finding deserves proper assessment rather than being filed under the kidney disease already known about.
Will a blood test for kidney function show kidney cancer?
No. Creatinine and eGFR measure how well your kidneys are filtering, and a tumour can sit in a kidney without changing those numbers at all, because the rest of that kidney and the kidney on the other side go on working. A completely normal kidney function report does not rule kidney cancer out. The reverse holds too: a raised creatinine or a low eGFR is far more likely to reflect chronic kidney disease, dehydration, a medicine or an acute illness than a tumour. Kidney cancer is found with imaging — an ultrasound first, then a contrast CT or an MRI when something needs characterising. Blood tests support the picture; they do not make the diagnosis.
Can kidney cancer be treated if I already have chronic kidney disease?
Yes, and it is a common combination. What changes is the planning, not whether treatment is possible. Reduced function affects how imaging is done, because the contrast dye used in CT has to be considered carefully — an ultrasound, a non-contrast scan or an MRI may be used instead. It affects how much kidney tissue can be spared. And it affects drug treatment for advanced disease: VEGF-targeted therapy can raise blood pressure and push protein into the urine, so both are monitored, and immunotherapy carries a risk of immune-related inflammation in the kidney. At CION, diagnosis, drug treatment and monitoring are led in-house by medical oncology, and surgery or ablation is coordinated with specialist partner centres alongside your kidney doctor.
Is blood in the urine a sign of kidney disease or kidney cancer?
It can come from either, and most often it is neither — a urinary infection, a stone, an enlarged prostate or hard exercise explains far more episodes than cancer does. Doctors separate blood you can see from blood found only on a urine dipstick, and blood accompanied by protein, which points towards a disease of the filtering units, from blood without it, which points towards something structural in the urinary tract. None of that can be worked out at home. A single painless episode of visible blood in the urine is always worth a prompt appointment, even if it clears the next day and never returns.
This page is general information about how kidney cancer, chronic kidney disease and kidney failure differ. It is not a diagnosis, a screening recommendation or a personal risk assessment. Only a doctor who has taken your history, examined you and reviewed your imaging and blood and urine results can tell you what your own reports mean.